Coming Soon...

Understanding Polycystic Kidney Disease (PKD)

Partnering with patients and families to slow progression, protect kidney health, and plan proactively for the future.

Developed by Craig G. Hurwitz, MD

πŸ“š ADPKD & ARPKDπŸ“„ Patient education
Step 1

Loading PKD Education Center...

If you are seeing this message, the page is still loading. The interactive education center will appear below in a moment.

Recommendation

β€”

Back to top
Educational information, not a substitute for medical advice. This page is for patient education and family discussion. Always review your individual situation with your nephrologist before making decisions about treatment, medications, lifestyle, or family screening.

Reference

Chapman AB, Devuyst O, Eckardt KU, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a KDIGO Controversies Conference. Kidney International 2015;88(1):17-27.

Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease (TEMPO 3:4). New England Journal of Medicine 2012;367(25):2407-2418.

Main Office

Northern Nephrology & Hypertension
52 Tom Miller Road
Plattsburgh, NY 12901
Phone: (518) 324-4000
Fax: (518) 324-4001

Office Hours: Mon-Fri 9AM-5PM

Β© 2026 Craig G. Hurwitz, MD β€” Northern Nephrology & Hypertension